Loading…
Loading…
EQUITY / NASDAQ · XNCM
GeoVax Labs, Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗0.3201 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 0.3201 USD · Volume 192,892
21 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Operating profit | -4,442,072 USD | -5,418,906 USD | — |
| Net income | -4,426,578 USD | -5,369,783 USD | — |
| Cash and cash equivalents | 3,143,422 USD | — | — |
| Total liabilities | 2,882,056 USD | — | — |
| Total equity | 1,760,701 USD | 2,821,196 USD | -37.59% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 3,143,422 USD | — | — | 3,085,741 USD | 3,085,741 USD | 5,008,997 USD | — | — |
| Net incomeIncome statement | -4,426,578 USD | -9,688,499 USD | -5,261,921 USD | — | -21,464,771 USD | -6,318,914 USD | -17,046,348 USD | -5,369,783 USD |
| Operating profitIncome statement | -4,442,072 USD | -9,714,953 USD | — | — | -21,639,047 USD | -6,373,215 USD | -17,197,291 USD | -5,418,906 USD |
| Total assetsBalance sheet | 4,642,757 USD | — | — | 6,341,868 USD | 6,341,868 USD | 6,731,255 USD | — | — |
| Total equityBalance sheet | 1,760,701 USD | — | 493,770 USD | 3,825,132 USD | 3,825,132 USD | 4,907,078 USD | — | 2,821,196 USD |
| Total liabilitiesBalance sheet | 2,882,056 USD | — | — | 2,516,736 USD | 2,516,736 USD | — | — | — |
| Capital expendituresCash flow statement | — | 0 USD | — | — | 27,612 USD | — | 27,612 USD | — |
| Financing cash flowCash flow statement | — | 7,253,505 USD | — | — | 19,080,381 USD | — | 16,041,861 USD | — |
| Investing cash flowCash flow statement | — | 0 USD | — | — | -27,612 USD | — | -27,612 USD | — |
| Operating cash flowCash flow statement | — | -7,195,824 USD | — | — | -21,473,969 USD | — | -16,512,193 USD | — |
| Report source | Open report ↗ Published: 07/27/2026 | Open report ↗ Published: 07/27/2026 | Open report ↗ Published: 07/27/2026 | Open report ↗ Published: 07/27/2026 | Open report ↗ Published: 04/15/2026 | Open report ↗ Published: 11/13/2025 | Open report ↗ Published: 11/13/2025 | Open report ↗ Published: 07/27/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.